DE69321883T2 - Delta-Antigen-Peptid des Hepatitis-D Virus enthaltende stabilisierte Zusammensetzungen - Google Patents

Delta-Antigen-Peptid des Hepatitis-D Virus enthaltende stabilisierte Zusammensetzungen

Info

Publication number
DE69321883T2
DE69321883T2 DE69321883T DE69321883T DE69321883T2 DE 69321883 T2 DE69321883 T2 DE 69321883T2 DE 69321883 T DE69321883 T DE 69321883T DE 69321883 T DE69321883 T DE 69321883T DE 69321883 T2 DE69321883 T2 DE 69321883T2
Authority
DE
Germany
Prior art keywords
compositions containing
antigen peptide
stabilized compositions
delta antigen
containing hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69321883T
Other languages
English (en)
Other versions
DE69321883D1 (de
Inventor
Ugo Barbieri
Maurizio Borla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diasorin SpA
Original Assignee
Wabco BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wabco BV filed Critical Wabco BV
Application granted granted Critical
Publication of DE69321883D1 publication Critical patent/DE69321883D1/de
Publication of DE69321883T2 publication Critical patent/DE69321883T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5765—Hepatitis delta antigen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DE69321883T 1992-06-08 1993-04-30 Delta-Antigen-Peptid des Hepatitis-D Virus enthaltende stabilisierte Zusammensetzungen Expired - Fee Related DE69321883T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920430A IT1255660B (it) 1992-06-08 1992-06-08 Composizioni stabilizzate di hdag.

Publications (2)

Publication Number Publication Date
DE69321883D1 DE69321883D1 (de) 1998-12-10
DE69321883T2 true DE69321883T2 (de) 1999-06-02

Family

ID=11401047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69321883T Expired - Fee Related DE69321883T2 (de) 1992-06-08 1993-04-30 Delta-Antigen-Peptid des Hepatitis-D Virus enthaltende stabilisierte Zusammensetzungen

Country Status (5)

Country Link
EP (1) EP0577565B1 (de)
AT (1) ATE173089T1 (de)
DE (1) DE69321883T2 (de)
ES (1) ES2126639T3 (de)
IT (1) IT1255660B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5848855A (ja) * 1981-09-17 1983-03-22 Green Cross Corp:The ＨＢｅ抗原の製法及びＨＢｅ抗体の検出試薬
EP0251575B2 (de) * 1986-06-17 2002-11-13 Chiron Corporation Hepatitis-Delta-Diagnostika und Impfstoffe, ihre Herstellung und Verwendung
WO1991006562A1 (en) * 1989-10-24 1991-05-16 University Of North Carolina At Chapel Hill Immunological domains of hepatitis delta virus antigen
IT1241003B (it) * 1990-11-05 1993-12-27 Sorin Biomedica Spa Procedimento per la purificazione di un polipeptide ricombinante hdag equivalente, polipeptide hdag equivalente e saggi immunologici che lo utilizzano

Also Published As

Publication number Publication date
ES2126639T3 (es) 1999-04-01
IT1255660B (it) 1995-11-09
ITRM920430A0 (it) 1992-06-08
EP0577565A2 (de) 1994-01-05
ATE173089T1 (de) 1998-11-15
DE69321883D1 (de) 1998-12-10
EP0577565A3 (de) 1994-03-16
ITRM920430A1 (it) 1993-12-08
EP0577565B1 (de) 1998-11-04

Similar Documents

Publication Publication Date Title
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
GR3006171T3 (de)
WO1992017493A3 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
EP0442394A3 (en) Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
DE69002152T2 (de) Abgasrückführventil.
DE3650289T2 (de) Spike-protein des virus der infektiösen bronchitis.
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
EP0326490A3 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
ATE173089T1 (de) Delta-antigen-peptid des hepatitis-d virus enthaltende stabilisierte zusammensetzungen
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
KR870010183A (ko) 합성 펩티드를 함유하는 복합 면역원
DK0779297T3 (da) Antigene peptider med glycinsubstitutioner
IL106592A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
FI943929A0 (fi) Hepatiitti C-viruspeptidejä
AU4645396A (en) Synthetic multimeric peptide with delta hepatitis virus antigenic activity
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
EP0637631A3 (de) Hoch effiziente Expression eines Polypeptids, das eine modifizierte preS1-Region des grossen Hepatitis B-Virus-Antigens enthält.
ATE416781T1 (de) Antigene modifikation von polypeptiden
FI952778A (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
EP0953642A4 (de) Antigenprotein aus infektiöse laryngotracheitis viren
NO950527D0 (no) Analogifremgangsmåte ved fremstilling av non-A, non-B hepatittvirus-antigenpeptid
KR970032889A (ko) B형 간염 바이러스의 펩타이드 항원을 함유하는 리포좀
KR920018313U (ko) 기체의 흡 · 배출용 캡밸브

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DIASORIN INTERNATIONAL INC., NEW YORK, N.Y., US

8327 Change in the person/name/address of the patent owner

Owner name: DIASORIN S.R.L., SALUGGIA, VERCELLI, IT

8339 Ceased/non-payment of the annual fee